Breast (women):
• Mammography annually 45−54 y (option start 40 y).
• ≥55 y: annual or biennial; continue if life expectancy ≥10 y.
• Clinical breast exam & self-exam no longer routinely recommended; rely on awareness.
Cervix (women):
• 21−29 y: Pap test q3 y.
• 30−65 y: preferred co-testing (Pap + HPV) q5 y; or Pap alone q3 y.
• Stop after 65 y if adequate negative prior screens & no high-risk history.
Terminology Highlights
Benign vs. malignant; neoplasm; carcinoma; sarcoma; metastasis; grading/staging (classification not detailed in excerpt).
Key treatment-related terms: alopecia, stomatitis, leukopenia, thrombocytopenia, palliative, etc.
Special Populations
Older adults: highest incidence; common sites = prostate, lung, breast, colorectal; signs may mimic normal aging → stress routine screening.
Cultural patterns: Asian-Americans lowest death rate; Native-Americans lowest incidence but poorest survival.